FDA-AA is designed to support the development of drugs that treats serious or life- threatening conditions AND generally provides a meaningful advantage over available
View this resource Bookmark this resource
FDA Expedited Program for serious conditions – Priority Review Designation
Published by IRDiRC
Regulatory AffairsEarly Access SupportRegulatory AdviceAccelerated Aproval